3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Malignant Solid Neoplasm
1
Kidney Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
HIV Infections
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Cigarette Smoking-Related Carcinoma
1
Carcinoma, Renal Cell
1
Interventions
Dexamethasone
46
Lenalidomide
30
Bortezomib
24
daratumumab
23
pomalidomide
20
Cyclophosphamide
16
carfilzomib
15
Specimen Handling
14
Biopsy
14
Calcium Dobesilate
12
isatuximab
11
Magnetic Resonance Spectroscopy
10
talquetamab
9
Melphalan
8
iberdomide
7
fludarabine
7
belantamab mafodotin
6
tocilizumab
5
selinexor
5
dexamethasone acetate
5
dexamethasone 21-phosphate
5
auricularum
5
X-Rays
5
fludarabine phosphate
4
elotuzumab
4
Sirolimus
4
Nuclear Medicine Department, Hospital
4
trametinib
3
dabrafenib
3
Whole-Body Irradiation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Multiple Myeloma
×
Health Promotion
×
30 days
×
Clear all
No trials found.